Sinopharm BBIBP-CorVi and Myocarditis: A Causal Link?
PDF

Keywords

Myocarditis
Covid 19 vaccination
attenuated vaccine
Sinopharm BBIBP-CorVi

Categories

How to Cite

1.
Elkhadi A, Motiaa Y, Aabdi M, Labib S, Sbai H. Sinopharm BBIBP-CorVi and Myocarditis: A Causal Link?. Integr J Med Sci [Internet]. 2022 Aug. 22 [cited 2022 Sep. 28];9. Available from: https://mbmj.org/index.php/ijms/article/view/646

Abstract

Since the introduction of the SARS-CoV-2 vaccine, several side effects have been reported, including acute myocarditis, which is primarily associated with mRNA vaccines. However, the cardiac side effects of other forms of vaccination against COVID-19 are still unknown.
Here, we present a case of a possible connection between myocarditis and attenuated vaccine Sinopharm BBIBP-CorV. An 18-year-old female patient was admitted to the intensive care unit (ICU) for the management of respiratory distress associated with hemodynamic instability one week after receiving an attenuated vaccine
Myocarditis has been reported as a complication of SARS-CoV-2 mRNA vaccines. Our case report suggests a possible link between myocarditis and attenuated vaccines. Therefore, more research is warranted to determine this causal link.

https://doi.org/10.15342/ijms.2022.646
PDF

References

Levin D, Shimon G, Fadlon-Derai M, Gershovitz L, Shovali A, Sebbag A, et al. Myocarditis following COVID-19 vaccination - A case series. Vaccine. 2021;39(42):6195–200. Available from: http://dx.doi.org/10.1016/j.vaccine.2021.09.004

Nassar M, Nso N, Gonzalez C, Lakhdar S, Alshamam M, Elshafey M, et al. COVID-19 vaccine-induced myocarditis: Case report with literature review. Diabetes Metab Syndr. 2021;15(5):102205. Available from: http://dx.doi.org/10.1016/j.dsx.2021.102205

Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese center for disease control and prevention: Summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323(13):1239–42. Available from: http://dx.doi.org/10.1001/jama.2020.2648

Rao S, Lau A, So H-C. Exploring diseases/traits and blood proteins causally related to expression of ACE2, the putative receptor of SARS-CoV-2: A Mendelian randomization analysis highlights tentative relevance of diabetes-related traits. Diabetes Care. 2020;43(7):1416–26. Available from: http://dx.doi.org/10.2337/dc20-0643

Plac¸ Ais L, Richier Q. COVID-19: Clinical, biological and radiological characteristics in adults, infants and pregnant women. An up-to-date review at the heart of the pandemic. Rev Med Intern. 2020;41(5):308–18. Available from: https://doi.org/10.1016/j.revmed.2020.04.004

Tony L Goldberg. Possible side effects after getting a COVID-19 Vaccine. J Evol Med. 2021;9(6). Available from: https://www.ashdin.com/articles/possible-side-effects-after-getting-a-covid19-vaccine.pdf

Albert E, Aurigemma G, Saucedo J, Gerson DS. Myocarditis following COVID-19 vaccination. Radiol Case Rep. 2021;16(8):2142–5. Available from: http://dx.doi.org/10.1016/j.radcr.2021.05.033

Caforio ALP, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(33):2636–48, 2648a–2648d. Available from: http://dx.doi.org/10.1093/eurheartj/eht210

Bock CT, Klingel K, Kandolf R, Human parvovirus B19- associated myocarditis. N Engl J Med. 2010;362:1248–9. Available from: https://doi.org/10.1056/nejmc0911362

Tschöpe C, Bock C-T, Kasner M, Noutsias M, Westermann D, Schwimmbeck P-L, et al. High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation. 2005;111(7):879–86. Available from: http://dx.doi.org/10.1161/01.CIR.0000155615.68924.B3

Cooper LT. Myocarditis. N Engl J Med. 2009; 360:1526-38. Available from: https://doi.org/10.1056/nejmra0800028

Keinath K, Church T, Kurth B, Hulten E. Myocarditis secondary to smallpox vaccination. BMJ Case Rep. 2018;bcr-2017-223523. Available from: http://dx.doi.org/10.1136/bcr-2017-223523

Nagano N, Yano T, Fujita Y, Koyama M, Hasegawa R, Nakata J, et al. Hemodynamic collapse after influenza vaccination: A vaccine-induced fulminant myocarditis? Can J Cardiol [Internet]. 2020;36(9):1554.e5-1554.e7. Available from: http://dx.doi.org/10.1016/j.cjca.2020.05.005

Mevorach D, Anis E, Cedar N, Hasin T, Bromberg M, Goldberg L, et al. Myocarditis after BNT162b2 vaccination in Israeli adolescents. N Engl J Med. 2022;386(10):998–9. Available from: http://dx.doi.org/10.1056/NEJMc2116999

Montgomery J, Ryan M, Engler R, Hoffman D, McClenathan B, Collins L, et al. Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military. JAMA Cardiol. 2021;6(10):1202–6. Available from: http://dx.doi.org/10.1001/jamacardio.2021.2833

Kim HW, Jenista ER, Wendell DC, Azevedo CF, Campbell MJ, Darty SN, et al. Patients with acute myocarditis following mRNA COVID-19 vaccination. JAMA Cardiol. 2021;6(10):1196–201. Available from: https://dx.doi.org/10.1001/jamacardio.2021.2828

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2022 Abdelhak Elkhadi, Youssef Motiaa, Mohammed Aabdi, Smael Labib, Hicham Sbai

Downloads

Download data is not yet available.